Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer.

MLA

Luchenko, Victoria L., et al. “Schedule-Dependent Synergy of Histone Deacetylase Inhibitors with DNA Damaging Agents in Small Cell Lung Cancer.” Cell Cycle (Georgetown, Tex.), vol. 10, no. 18, Sept. 2011, pp. 3119–28. EBSCOhost, https://doi.org/10.4161/cc.10.18.17190.

APA

Luchenko, V. L., Salcido, C. D., Zhang, Y., Agama, K., Komlodi-Pasztor, E., Murphy, R. F., Giaccone, G., Pommier, Y., Bates, S. E., & Varticovski, L. (2011). Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer. Cell Cycle (Georgetown, Tex.), 10(18), 3119–3128. https://doi.org/10.4161/cc.10.18.17190

Chicago

Luchenko, Victoria L, Crystal D Salcido, Yongwei Zhang, Keli Agama, Edina Komlodi-Pasztor, Robert F Murphy, Giuseppe Giaccone, Yves Pommier, Susan E Bates, and Lyuba Varticovski. 2011. “Schedule-Dependent Synergy of Histone Deacetylase Inhibitors with DNA Damaging Agents in Small Cell Lung Cancer.” Cell Cycle (Georgetown, Tex.) 10 (18): 3119–28. doi:10.4161/cc.10.18.17190.